Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2015) 38 MTE7 | DOI: 10.1530/endoabs.38.MTE7

SFEBES2015 Meet the Expert Sessions (1) (10 abstracts)

Designer receptors exclusively activated by designer drugs (DREADD) – novel pharmacological handles on the endocrine system

Alastair Garfield 1,


1University of Edinburgh, Edinburgh, UK; 2Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.


Chemogenetic technologies afford the real-time control of molecularly-defined populations of neurons in a spatially and temporally specific fashion. The ability to remotely activate and silence neurons within the context of genetically-intact freely behaving mice provides unprecedented insight into their physiological function and pathological potential. Used in combination with other genetically-encoded tools this approach facilitates the deconvolution of the neural circuitry governing sensorimotor responses to (patho)physiological state. Here we review the principles and applications of chemogenetics, drawing upon our recent research into the discrete circuits that regulate homeostatic hunger/satiety and counter-regulatory autonomic responses to hypoglycemia, respectively.

Volume 38

Society for Endocrinology BES 2015

Edinburgh, UK
02 Nov 2015 - 04 Nov 2015

Society for Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.

Authors